Get to know our clinical trials

Clinical trial to evaluate the safety and durability of GT005 in participants with geographic atrophy secondary to age-related macular degeneration treated in a previous Gyroscope-sponsored study

THE AIM OF THIS STUDY IS TO LEARN ABOUT THE POSSIBLE LONG-TERM EFFECTS OF GT005 TREATMENT AND TO DETERMINE WHETHER GT005 IS SAFE IN THE LONG TERM FOR PATIENTS WITH GA DUE TO AMD.

Navarre headquarters
Madrid headquarters
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • LONG-TERM FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND DURABILITY OF GT005 IN PARTICIPANTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION TREATED IN A PREVIOUS GYROSCOPE-SPONSORED STUDY
  • Code EudraCT: 2020-003987-22
  • Protocol number: GT-ORACLE
  • Promoter: Gyroscope Therapeutics

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.